达比加群酯是否能改善心房颤动的卒中预防？一篇反驳文章。 - Suppr

Suppr

超能文献

Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal.

作者信息

Stöllberger C, Finsterer J

出版信息

J Thromb Haemost. 2010 Jun;8(6):1436-7; author reply 1438-9. doi: 10.1111/j.1538-7836.2010.03738.x. Epub 2010 Jan 17.

DOI:10.1111/j.1538-7836.2010.03738.x

PMID:20088945

Abstract

摘要

相似文献

Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal.

J Thromb Haemost. 2010 Jun;8(6):1436-7; author reply 1438-9. doi: 10.1111/j.1538-7836.2010.03738.x. Epub 2010 Jan 17.

Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.

Mo Med. 2012 Mar-Apr;109(2):146-9.

Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.

Stroke. 2010 Jun;41(6):1307-9. doi: 10.1161/STROKEAHA.110.584557. Epub 2010 Apr 15.

FDA committee unanimously recommends approval of dabigatran etexilate for stroke prevention in atrial fibrillation.

Cardiovasc J Afr. 2010 Nov-Dec;21(6):341.

Atrial fibrillation: A promising new anticoagulant for stroke prevention.

Nat Rev Cardiol. 2010 Jan;7(1):10-1. doi: 10.1038/nrcardio.2009.220.

Dabigatran etexilate in people with atrial fibrillation.

BMJ. 2010 Jul 29;341:c3784. doi: 10.1136/bmj.c3784.

[Chinese practical guide of dabigatran etexilate for stroke prevention in patients with non-valvular atrial fibrillation].

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Mar;42(3):188-92.

Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk.

Lancet Neurol. 2010 Dec;9(12):1140-1142. doi: 10.1016/S1474-4422(10)70275-1. Epub 2010 Nov 6.

The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients.

Vasc Health Risk Manag. 2013;9:341-52. doi: 10.2147/VHRM.S28271. Epub 2013 Jul 9.

Anti-thrombotic trials in atrial fibrillation, the RELY study.

Cardiovasc J Afr. 2010 Sep-Oct;21(5):299.

引用本文的文献

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.

PLoS One. 2010 Jul 19;5(7):e11658. doi: 10.1371/journal.pone.0011658.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal.

作者信息

Stöllberger C, Finsterer J

出版信息

J Thromb Haemost. 2010 Jun;8(6):1436-7; author reply 1438-9. doi: 10.1111/j.1538-7836.2010.03738.x. Epub 2010 Jan 17.

DOI:10.1111/j.1538-7836.2010.03738.x

PMID:20088945

Abstract

摘要

相似文献

Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal.

J Thromb Haemost. 2010 Jun;8(6):1436-7; author reply 1438-9. doi: 10.1111/j.1538-7836.2010.03738.x. Epub 2010 Jan 17.

Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.

Mo Med. 2012 Mar-Apr;109(2):146-9.

Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.

Stroke. 2010 Jun;41(6):1307-9. doi: 10.1161/STROKEAHA.110.584557. Epub 2010 Apr 15.

FDA committee unanimously recommends approval of dabigatran etexilate for stroke prevention in atrial fibrillation.

Cardiovasc J Afr. 2010 Nov-Dec;21(6):341.

Atrial fibrillation: A promising new anticoagulant for stroke prevention.

Nat Rev Cardiol. 2010 Jan;7(1):10-1. doi: 10.1038/nrcardio.2009.220.

Dabigatran etexilate in people with atrial fibrillation.

BMJ. 2010 Jul 29;341:c3784. doi: 10.1136/bmj.c3784.

[Chinese practical guide of dabigatran etexilate for stroke prevention in patients with non-valvular atrial fibrillation].

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Mar;42(3):188-92.

Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk.

Lancet Neurol. 2010 Dec;9(12):1140-1142. doi: 10.1016/S1474-4422(10)70275-1. Epub 2010 Nov 6.

The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients.

Vasc Health Risk Manag. 2013;9:341-52. doi: 10.2147/VHRM.S28271. Epub 2013 Jul 9.

Anti-thrombotic trials in atrial fibrillation, the RELY study.

Cardiovasc J Afr. 2010 Sep-Oct;21(5):299.

引用本文的文献

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.

PLoS One. 2010 Jul 19;5(7):e11658. doi: 10.1371/journal.pone.0011658.